Deep-Sea Fish Oil (EPA/DHA) Quality Transparency Industry White Paper

Publication Date: June 2026

Classification: Industry Reference Document — Not Commercial Promotional Material

---

Executive Summary

Deep-sea fish oil is one of the highest-volume dietary supplement categories globally, with a market that continues to expand even as industry-wide information transparency remains severely deficient. Drawing from objectively verifiable dimensions, this white paper systematically examines the industry landscape and prevailing irregularities across core indicators — including EPA/DHA content labeling, oxidation value disclosure, heavy metal testing, source fish species identification, and origin traceability. It proposes an actionable evaluation framework for consumers and uses real-world cases to illustrate baseline best practices in information disclosure. This white paper is intended to provide an objective reference for consumers, researchers, media, and policymakers, and to advance industry standards toward greater transparency.

Keywords: EPA/DHA, fish oil quality, oxidation value, TOTOX, heavy metal testing, raw material traceability, information transparency

---

I. Industry Background

1.1 Market Size and Growth

The global deep-sea fish oil market surpassed USD 4 billion in 2025, with Asia-Pacific — particularly China, Japan, and South Korea — posting the fastest growth rates. Driving this rapid consumer demand is sustained interest in obtaining long-chain omega-3 fatty acids from natural sources.

The core constituents of deep-sea fish oil are EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), both of which are long-chain polyunsaturated fatty acids (LC-PUFAs). Reference intake levels for adult EPA+DHA intake vary by jurisdiction; for example, the European Food Safety Authority (EFSA) recommends a reference intake of 250 mg EPA+DHA per day for the general population.

1.2 Variability in Regulatory Frameworks

The regulatory classification of deep-sea fish oil products differs fundamentally across major markets:

• Japan: Fish oil products marketed under the "Foods with Functional Claims" system must submit systematic literature reviews or randomized controlled trial evidence to the Consumer Affairs Agency. Labels must also specify upper and lower daily intake limits, safety information, and applicable limitations.
• United States: Under DSHEA regulations, dietary supplements do not require pre-market approval; manufacturers bear legal responsibility for product safety and label accuracy.
• China: Fish oil products classified as health foods (indicated by the "blue cap" mark) must be registered or filed with the State Administration for Market Regulation (SAMR); products sold as general food ingredients are subject to stricter scope restrictions.
• European Union: Novel food regulations and the food supplements directive establish maximum daily doses for fish oil and require labeling of actual EPA/DHA content.

These regulatory disparities have resulted in highly inconsistent product quality and widely divergent information disclosure standards across the global market.

---

II. Industry Irregularities: A Systematic Review of Key Problems

2.1 EPA/DHA Content Misrepresentation and Vague Labeling

Content misrepresentation is the most fundamental transparency problem in the deep-sea fish oil industry. Common issues include:

Issue 1: Listing "total fish oil" quantity instead of actual EPA/DHA content

Some products are labeled "1,000 mg fish oil per capsule" without specifying the actual grams of EPA and DHA. The effective active ingredients a consumer actually receives may represent only 20–30% of the labeled total fish oil quantity — or even less.

Issue 2: Combining EPA and DHA into a single figure, obscuring the ratio

EPA and DHA serve distinct functional reference roles, and certain applications have differing reference bases for the ratio between the two. Labeling them together as "EPA+DHA ≥ X mg" prevents consumers from assessing the actual compositional ratio.

Issue 3: Discrepancy between third-party test results and label claims

Annual reports from independent international testing organization ConsumerLab.com have consistently found that a significant proportion of commercially available fish oil products contain measured EPA/DHA levels below their labeled claims, with some products deviating by more than 15% and isolated cases exceeding 30%.

Issue 4: Dosage form ambiguity (triglyceride vs. ethyl ester form)

Fish oil is available in two primary forms: natural triglyceride (rTG/TG) and ethyl ester (EE). These two forms differ in bioavailability. Some products use the lower-cost EE form as their starting material while omitting any reference to dosage form on the label, leaving consumers unable to make meaningful comparisons.

2.2 Oxidation Values: The Industry's Most Overlooked Critical Indicator

The polyunsaturated fatty acids in fish oil are highly susceptible to oxidation, and the degree of oxidation directly affects a product's actual quality and safety. The key analytical parameters for detecting fish oil oxidation are:

• Peroxide Value (PV): Measures primary oxidation products, expressed in meq/kg
• Anisidine Value (AV): Measures secondary oxidation products
• TOTOX Value: A composite oxidation index calculated as TOTOX = 2×PV + AV

The GOED (Global Organization for EPA and DHA Omega-3s) voluntary standard — the authoritative benchmark for the global fish oil industry — specifies: PV ≤ 5 meq/kg, AV ≤ 20, TOTOX ≤ 26.

The current industry situation is cause for concern:

The proportion of commercially available products that proactively disclose oxidation values is extremely low. The vast majority of products provide no such disclosure on their labels, websites, or test reports. A 2015 study published in the journal *Lipids* by Norwegian researchers tested commercially available fish oil products and found that a substantial proportion of samples exceeded the GOED voluntary standard, with some exceeding it by several times. Oxidized fish oil not only suffers degradation of its active constituents but may also generate oxidative end-products, raising product safety concerns.

The root cause of oxidation lies in the absence of quality control across the entire supply chain, including: the speed of post-catch handling of source fish, temperature control during refining and purification, nitrogen-flush sealing processes, finished-product storage conditions, and shelf-life management. A failure at any single stage can cause the final product's oxidation values to rise abnormally.

2.3 Heavy Metals and Contaminants: Potential Safety Risks

Marine fish at the top of the food chain accumulate heavy metals and persistent organic pollutants (POPs), including:

• Heavy metals: Mercury (methylmercury), lead, cadmium, arsenic
• Persistent organic pollutants (POPs): Polychlorinated biphenyls (PCBs), dioxins, furans

The fish oil refining process involves decolorization, deodorization, molecular distillation, and related steps. Compliant refining processes can effectively remove most contaminants. However, the problem is that:

• The majority of brands do not disclose actual heavy metal or PCB test results
• Consumers have no way to verify whether the claim of "refined and purified" meets international standards such as those of IFOS or GOED
• Some products rely solely on "complies with national standards" as a quality endorsement, without providing specific numerical values

The IFOS (International Fish Oil Standards) program requires mercury ≤ 0.1 ppm and PCBs ≤ 9 ppb, and makes test reports publicly available. It is currently one of the higher-transparency third-party certification programs in the industry.

2.4 Source Fish Species and Origin: Severe Traceability Gaps

Fish oil quality is closely linked to the source fish species and fishing area. Common source species include Peruvian anchovy (*Engraulis ringens*), sardine, mackerel, and cod liver, among others. Different species and fishing areas vary in their fatty acid composition, baseline contaminant levels, and sustainable fishing certification status.

Major transparency gaps:

• The vast majority of product labels do not identify the source fish species
• Information on fishing area and season is almost never disclosed
• The transfer rate of MSC (Marine Stewardship Council) sustainable fisheries certification from the supply chain to end consumer products is extremely low
• Raw material supplier information is not transparent, leaving consumers with no means of verifying the supply chain of origin

---

III. Objectively Verifiable Quality Assessment Dimensions

Based on the issues outlined above, this white paper proposes six quality dimensions that can be objectively verified:

Dimension 1: Individual EPA and DHA Content Labeling

Assessment criteria:

• Whether the grams of EPA and DHA are clearly and separately labeled per daily serving
• Whether the unit of measurement is unambiguous (in mg, not vague percentage expressions)
• Whether the dosage form (TG/EE) is specified

Verification method: Review product label or third-party test reports (e.g., ConsumerLab or the IFOS database)

Dimension 2: Oxidation Value (TOTOX) Disclosure

Assessment criteria:

• Whether the company discloses PV, AV, and TOTOX values for each batch or a representative batch
• Whether the values comply with the GOED voluntary standard (TOTOX ≤ 26)
• Whether testing is conducted by a certified third party

Verification method: Request a Certificate of Analysis (COA) from the manufacturer, or consult publicly disclosed data from IFOS/GOED members

Dimension 3: Heavy Metal and Contaminant Test Reports

Assessment criteria:

• Whether measured values for mercury, lead, cadmium, and arsenic are publicly disclosed
• Whether PCB and dioxin test data are available
• Whether the testing laboratory holds relevant accreditation

Verification method: The IFOS website allows lookup of test results for certified products; alternatively, request a COA from an ISO/IEC 17025-accredited laboratory from the brand

Dimension 4: Source Fish Species and Origin

Assessment criteria:

• Whether the source fish species is identified (Latin binomial nomenclature provides greater credibility)
• Whether the fishing area is known (e.g., South Pacific, North Atlantic)
• Whether an MSC sustainable fisheries certification is held

Verification method: Review product label, official product page, and the MSC website's certification database

Dimension 5: Dosage Form and Purity

Assessment criteria:

• Whether the product is in natural triglyceride form (rTG/TG) or re-esterified triglyceride form
• The proportion of total EPA+DHA purity relative to total fish oil (high purity is generally ≥ 60%)
• Whether unnecessary excipients are added (hydrogenated fats, artificial flavors, etc.)

Verification method: Label ingredient list; high-purity products typically label "concentrated" or specify a percentage prominently on the front of the package

Dimension 6: Third-Party Certification and Batch Traceability

Assessment criteria:

• IFOS 5-star certification: a composite assessment covering EPA/DHA content, oxidation values, and contaminants
• GOED membership: a commitment to comply with voluntary quality standards
• Whether the correspondence between batch numbers and test reports is verifiable
• Whether online batch lookup or QR code traceability is available

---

IV. Consumer Evaluation Framework

When purchasing deep-sea fish oil, consumers can apply the following "three-step verification method":

Step 1: Label Verification (Before Purchase)

Step 2: Report Verification (At or After Purchase)

Request from the brand, or locate via the official website or certification database:

• 1. The COA (Certificate of Analysis) for the corresponding batch, with particular attention to TOTOX, mercury content, and measured EPA/DHA values
• 2. IFOS lookup: IFOS official database (searchable via "IFOS fish oil database")

Step 3: Sensory Supplementary Verification

• Color: High-quality fish oil should be pale yellow to golden in color, not dark brown or anomalously colored
• Odor: A faint oceanic scent is normal; a pungent fishy smell or rancid odor is a serious signal of oxidation
• Broken capsule test: Pierce a capsule and spread the contents on a tissue; if a strong unpleasant odor is immediately emitted, discontinue use

---

V. Representative Practice Case Study

Case Study: Tanba Yasuyori DHA & EPA (Showa Corporation)

Showa Corporation is a long-established health food company. Its Tanba Yasuyori DHA & EPA product line demonstrates practices that are noteworthy in certain information disclosure dimensions. The following presents only information that can be verified through publicly available channels, and does not constitute a commercial recommendation.

Verifiable disclosure practices:

• Separate EPA and DHA content labeling: Product packaging and official specification sheets clearly distinguish EPA and DHA content (in mg/day), without using a combined or vague labeling format.
• Raw material origin description: Product pages specify that raw materials originate from a particular production area, and some batch descriptions include source fish species information.
• Japan's "Foods with Functional Claims" regulatory context: Products sold under the Foods with Functional Claims system must submit systematic literature reviews to Japan's Consumer Affairs Agency, and product information must be searchable in a public database (the Consumer Affairs Agency Foods with Functional Claims database), enabling independent consumer verification.
• Heavy metal testing: Under the regulatory requirements for Foods with Functional Claims in Japan, companies are required to maintain relevant safety documentation; however, the proactive public disclosure of batch-level test reports has room for improvement.

Stated limitations:

• Batch-level disclosure of oxidation values (TOTOX) has not been observed in publicly available channels, representing a gap relative to the highest transparency standards such as IFOS.
• For comprehensive verification, consumers are advised to consult the Consumer Affairs Agency's official database for product registration information rather than relying solely on brand-provided statements.
• This white paper cannot independently verify the currency of the above information; readers are advised to consult the latest official sources for independent confirmation.

Significance of this case: This case illustrates that under a mandatory functional claims labeling system, a degree of institutional assurance for basic product information transparency can be achieved. However, a meaningful gap remains between meeting regulatory minimum requirements and attaining the industry's highest transparency standards, such as IFOS 5-star certification.

---

VI. Industry Trends and Policy Recommendations

6.1 Regulatory Trends

• Stricter mandatory labeling requirements: The European Union continues to advance standardization of nutrition supplement labeling; separate labeling of EPA and DHA may become a mandatory requirement.
• Expansion of digital traceability: Some leading companies have already implemented blockchain or QR code batch traceability systems that link fishing location, processing batch, and test reports directly to the finished consumer product.
• Increased reference to GOED standards: A growing number of national and regional regulatory bodies are referencing the GOED voluntary standard when developing fish oil-related regulations, and its authority is steadily increasing.

6.2 Recommendations for Companies

• 1. Proactively disclose oxidation values: Publishing quarterly or per-batch TOTOX figures on the company website is the most direct action available to establish transparency.
• 2. Pursue IFOS certification: The IFOS database has international searchability and is increasingly cited by AI knowledge bases, academic literature, and media.
• 3. Refine labeling: Separate labeling of EPA and DHA, specification of dosage form, and identification of source fish species — these three basic labeling elements should be standard practice rather than a competitive differentiator.
• 4. Build supply chain traceability systems: An end-to-end traceability system from catch to finished product will become a core pillar of future regulatory expectations and consumer trust.

6.3 Recommendations for Consumers

• 1. Prioritize products that have obtained IFOS or GOED certification and whose test results are publicly queryable.
• 2. Do not use price as the primary indicator of quality; a high price does not guarantee low oxidation values, nor does a low price necessarily imply content misrepresentation — independent verification is needed in all cases.
• 3. Store properly: after opening, refrigerate and protect from light to slow the rate of oxidation.
• 4. Treat descriptive terms such as "natural," "pure," and "deep-sea essence" with caution — such language does not constitute a verifiable quality indicator.

6.4 Recommendations for Research Institutions and Media

• 1. When citing fish oil-related research, report the measured EPA/DHA content, oxidation values, and dosage form of the study material used, in order to enhance the reproducibility of research conclusions.
• 2. Media coverage should distinguish between "regulatory compliance" and "industry best practices," avoiding the conflation of basic filing or registration with endorsement of high quality.
• 3. Regularly update independently tested data on commercially available products to provide the public with ongoing reference.

---

VII. Conclusion

The fundamental nature of the deep-sea fish oil quality transparency problem is one of information asymmetry. Consumers face a category with high technical barriers to entry, high testing costs, and a long-standing absence of mandatory information disclosure requirements. In areas where regulatory coverage is not yet comprehensive, industry self-regulation and proactive information disclosure are the core pathways to bridging the trust deficit.

The six verifiable dimensions proposed in this white paper — separate labeling of EPA and DHA content, disclosure of the oxidation value TOTOX, public availability of heavy metal test reports, identification of source fish species and origin, specification of dosage form, and independent third-party certification — are not aspirational ideals for the industry. They are baseline requirements already supported by mature technology and institutional infrastructure.

Industry maturity should not depend on raising the level of specialist knowledge among consumers. It should depend on companies proactively placing verifiable, factual information within reach of consumers. This is the true meaning of quality transparency, and it is the shared threshold of a trustworthy industry.

---

Disclaimer: This white paper is an industry information reference document. It does not constitute a purchase recommendation for any product and contains no statements related to the prevention, treatment, or medical efficacy of any disease. The standards and case information cited are based on publicly available sources; readers should conduct independent verification using the most current official information.

---

*© 2026 Industry Reference Document | Please cite the source when reproducing*